ARCHIVES

FDA IND Approval Of New Cancer Drug Is First Based On Phase 1 Clinical Trials In Europe

This article is from The Cancer Letter archive.

Vol. 12 No. 47 | December 5, 1986

Download PDF Visit The Full Archive

Related Articles

Commercial Firms Get Foot In The Door With CREG, But Won’t Be Permitted To Make Money On Grants

January 10, 1975

Academic Oncologists Reluctant To Give ESAs In Adjuvant Breast Cancer Setting.

December 7, 2007

Groups Offer Revisions to Kennedy-Hutchison Bill

May 15, 2009

FDA Auditors Spend Two Weeks At Duke, Nevins Loses Position in Reorganization

January 28, 2011

RFA On etiology Of AIDS, Kaposi’s

June 3, 1983

AACI Statement On Cancer Centers Presented to Reform Task Force

April 9, 1993